Cochrane review finds anti-amyloid Alzheimer's drugs offer no meaningful clinical benefit.

Major pharma companies raised drug prices despite deals with the Trump administration.

Revolution Medicines' daraxonrasib shows promising results in pancreatic cancer trial.

FDA approves first FSGS treatment for patients 8+ without nephrotic syndrome.

Novo Nordisk partners with OpenAI to use AI for faster drug discovery and lower costs.

India targets global pharma leadership through innovation initiatives.

World Hemophilia Day highlights early diagnosis and treatment barriers, with new gene therapy promising a potential cure.

NZ expands cancer care with $814M investment for 13,000 new infusions.

Telix and Regeneron partner to develop radiopharmaceutical therapies for solid tumors.

OpenAI launched GPT-Rosalind, a new AI model for life sciences research.